|
|
|
|
|
|
|
05.05.25 - 22:18
|
Ingevity reports first quarter 2025 financial results (Business Wire)
|
|
|
HIGHLIGHTS:
Net sales of $284.0 million, down 17% compared to prior year, primarily due to repositioning actions in Performance Chemicals, which included the exit of certain lower-margin end markets
Net income of $20.5 million and diluted earnings per share (EPS) of $0.56 reflects before-tax special charges of $20.2 million; adjusted earnings of $36.4 million and diluted adjusted EPS of $0.99
Adjusted EBITDA of $91.3 million increased 23% and adjusted EBITDA margin improved to 32.1% due primarily to the successful execution of repositioning actions in Performance Chemicals and continued strong profitability in Performance Materials
Operating cash flow of $25.4 million with free cash flow of $15.4 million
Ingevity widens its guidance range to reflect declines in industry forecasts of auto production due to trade tensions and tariff uncertainty; revised full year guidance of sales between $1.25 billion and $1.40 billion and adjusted EBITDA between $380 million and $415 million
The results and guidance in th...
|
|
|
24.04.25 - 15:09
|
Ingevity announces dates for first-quarter 2025 earnings release and webcast (Business Wire)
|
|
|
NORTH CHARLESTON, S.C.--(BUSINESS WIRE)--Ingevity Corporation (NYSE: NGVT) announced today that it will release its first-quarter 2025 earnings after the stock market close on Monday, May 5, 2025.
The company will host a live webcast on Tuesday, May 6, at 9:00 a.m. (Eastern) to discuss first-quarter 2025 fiscal results. The webcast can be accessed here or on the investors section of Ingevity's website.
Participants may also listen to the conference call by dialing 833 470 1428 (inside the U.S.) and entering access code 815699. Callers outside the U.S. can find global dial-in numbers here. For those unable to join the live event, a recording will be available beginning at approximately 2:00 p.m. (Eastern) on May 6, 2025, through May 5, 2026, at this replay link.
Information on how to access the webcast and conference call, along with a slide deck containing other relevant financial and statistical information, will be posted to the investors section of Ingevity's website prior to the call.
Ingevity: Puri...
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10.03.25 - 21:21
|
Ingevity announces appointment of David H. Li as president and CEO (Business Wire)
|
|
|
Li brings 25-year+ record of driving successful corporate transformation, long-term growth and stockholder value creation at premier global specialty materials supplier
NORTH CHARLESTON, S.C.--(BUSINESS WIRE)--Ingevity Corporation (NYSE:NGVT) today announced that its board of directors has appointed David H. Li as the company's president and CEO, effective as of April 7, 2025, and that he is expected to join the board of directors following the 2025 Annual Meeting. Li succeeds Ingevity board member, Luis Fernandez-Moreno, who has been serving as interim president and CEO since October 2024. Fernandez-Moreno will remain on Ingevity's board.
Li has more than 25 years of experience in the specialty materials industry. He most recently served as CEO, president and a member of the board of CMC Materials, Inc., a global supplier of advanced materials focused on the semiconductor and energy industries, prior to its sale to Entegris, Inc. in 2022.
“David (Dave) has a broad and proven track record of repositio...
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
18.02.25 - 22:18
|
Ingevity reports fourth quarter and full year 2024 financial results (Business Wire)
|
|
|
Fourth Quarter:
Net sales of $298.8 million decreased 20% compared to prior year primarily due to repositioning actions in the Performance Chemicals segment that resulted in the exit of lower-margin end markets
Net income of $16.6 million and diluted earnings per share (EPS) of $0.46, including pre-tax restructuring charges of $23.4 million; adjusted earnings of $34.7 million and diluted adjusted EPS of $0.95
Adjusted EBITDA of $80.6 million and adjusted EBITDA margin of 27.0%
Operating cash flow of $64.5 million and free cash flow of $39.6 million, which included the second and final $50.0 million installment of a termination fee for a long-term crude tall oil (CTO) supply agreement
Full Year:
Net sales of $1.4 billion decreased 17% compared to prior year primarily due to repositioning actions in the Performance Chemicals segment that resulted in the exit of lower-margin end markets
Net loss of $430.3 million and diluted loss per share of $11.85, including pre-tax charges of $688.0 million primarily rela...
|
|
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
